GRAIL

IPO

Multi-cancer early detection

GRAIL is a biotech company in Menlo Park, United States, founded in 2015. It has raised $2.1B across 6 rounds, most recently a $110.0M Corporate Round in June 2026.

Employees
1001–5000
Founded
2015
Business Model
B2B
Website
grail.com
Total Funding
$2.1B
Last Round
$110.0M Corporate RoundJun 2026
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.

About

GRAIL is a healthcare company focused on multi-cancer early detection (MCED) through its Galleri blood test, leveraging next-generation sequencing, machine learning, and large-scale clinical studies. Headquartered in Menlo Park, it aims to change the cancer trajectory by detecting deadly cancers early when more treatable.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundStrategic Equity FinancingJun 2026
$110.0M

6 more events

  • Corporate Round20251 investor
  • Acquisition2021
  • Series D2020

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Other ×6
  • Cloud/Infrastructure ×2
  • AI/ML ×1
  • Backend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Biotech
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GRAIL on Indexed.vc
<a href="https://indexed.vc/companies/grail"><img src="https://indexed.vc/api/badge/company/grail" alt="GRAIL on Indexed.vc" width="260" height="76" /></a>